EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $406,000 | -17.8% | 7,971 | -10.0% | 0.00% | – |
| Q3 2021 | $494,000 | +37.6% | 8,861 | +5.5% | 0.00% | – |
| Q2 2021 | $359,000 | -12.4% | 8,399 | -14.4% | 0.00% | – |
| Q1 2021 | $410,000 | -8.9% | 9,814 | +1.5% | 0.00% | – |
| Q4 2020 | $450,000 | +1.6% | 9,672 | -7.3% | 0.00% | – |
| Q3 2020 | $443,000 | -13.5% | 10,433 | -2.1% | 0.00% | -100.0% |
| Q2 2020 | $512,000 | +1.8% | 10,661 | -2.4% | 0.00% | 0.0% |
| Q1 2020 | $503,000 | -19.9% | 10,927 | +4.5% | 0.00% | 0.0% |
| Q4 2019 | $628,000 | -0.2% | 10,458 | -6.0% | 0.00% | 0.0% |
| Q3 2019 | $629,000 | +15.0% | 11,127 | +13.2% | 0.00% | 0.0% |
| Q2 2019 | $547,000 | +38.8% | 9,827 | +25.8% | 0.00% | 0.0% |
| Q1 2019 | $394,000 | +53.3% | 7,811 | +22.4% | 0.00% | – |
| Q4 2018 | $257,000 | – | 6,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |